Linear epitope mapping of peanut allergens demonstrates individualized and persistent antibody-binding patterns - 18/04/17
Doi : 10.1016/j.jaci.2016.06.019
Christian S. Hansen, PhD a, Martin Dufva, PhD b 
, Katrine L. Bøgh, PhD c, Eric Sullivan, PhD d, Jigar Patel, PhD d, Thomas Eiwegger, MD e, f, Zsolt Szépfalusi, MD e, Morten Nielsen, PhD a, g, Anders Christiansen, PhD b
, Katrine L. Bøgh, PhD c, Eric Sullivan, PhD d, Jigar Patel, PhD d, Thomas Eiwegger, MD e, f, Zsolt Szépfalusi, MD e, Morten Nielsen, PhD a, g, Anders Christiansen, PhD b a Center for Biological Sequence Analysis, Technical University of Denmark, Kgs Lyngby, Denmark
b Department of Micro- and Nanotechnology, Technical University of Denmark, Kgs Lyngby, Denmark
c National Food Institute, Technical University of Denmark, Søborg, Denmark
d Roche NimbleGen, Madison, Wis
e Department of Pediatrics, Medical University of Vienna, Vienna, Austria
f Division of Immunology and Allergy, Food Allergy and Anaphylaxis Program, the Department of Paediatrics, Hospital for Sick Children, Research Institute, Physiology and Experimental Medicine, the University of Toronto, Toronto, Ontario, Canada
g Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, Buenos Aires, Argentina
| The research leading to these results has received funding from the Danish National Advanced Technology Foundation (grant no. 128-2012-1), European Union Seventh Framework Programme (under grant no. 278832), the Austrian Science Fund (grant nos. SFB-F4609 and C117), and the Technical University of Denmark. |
|
| Disclosure of potential conflict of interest: C. S. Hansen receives grant support from the European Union Seventh Framework Programme (grant no. 278832; HiPAD) and is an employee of Evaxion Biotech. E. Sullivan is an employee of Roche NimbleGen Inc. J. Petal is an employee of Roche NimbleGen Inc. Z. Szépfalusis serves as a consultant for ThermoFisher; receives grant support from the Austrian Science Fund; and receives payment for lectures from Milupa, GSK, Medis, and Meda. M. Nielsen receives grant support from the European Union Seventh Framework Programme (grant no. 278832; HiPAD). A. Christiansen receives grant support from the Danish National Advanced Technology Foundation and Dr. Techn. A.N. Neergaard and Wife's Foundation; and travel support from Oticon Foundation. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2016
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 138 - N° 6
P. 1728-1730 - décembre 2016 Retour au numéro
Article précédent
- Platelet-activating factor decreases skin keratinocyte tight junction barrier integrity
- Su Duan, Kerstin Wanke, Paulina Wawrzyniak, Yifan Meng, Jeannette I. Kast, Beate Rückert, Ana Rebane, Mu Xian, Carsten Bindslev-Jensen, Sigurd Broesby-Olsen, Ulrike Raap, Thomas Werfel, Mübeccel Akdis, Luo Zhang, Cezmi A. Akdis
- A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria
- Jeffrey M. Harris, Christopher R. Cabanski, Heleen Scheerens, Divya Samineni, Mary S. Bradley, Colette Cochran, Petra Staubach, Martin Metz, Gordon Sussman, Marcus Maurer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?